
|Articles|May 24, 2019
Exploring Therapeutic Targets of the Beta Amyloid Pathway to Slow the Progression of Alzheimer Disease
https://www.pharmacytimes.org/on-demand/exploring-therapeutic-targets-of-the-beta-amyloid-pathway-to-slow-the-progression-of-alzheimer-disease
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
ACA Subsidy Expiration Raises Concerns for Behavioral Health Access and ED Strain
3
HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances
4
FDA Approves Intranasal Etripamil for Type of Arrhythmia
5








































